Literature DB >> 8253770

Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase.

T Miyagi1, K Konno, Y Emori, H Kawasaki, K Suzuki, A Yasui, S Tsuik.   

Abstract

We have isolated a cDNA clone encoding the cytosolic sialidase of rat skeletal muscle. Degenerate oligonucleotides, based on amino acid sequence data for the purified enzyme, were used as primers to amplify fragments of the gene from rat skeletal muscle cDNA by the polymerase chain reaction. The amplified cDNA fragment was then applied as probe to screen a rat skeletal muscle cDNA library. The longest cDNA clone thus isolated was incomplete at the 5'-end, and therefore an amplified cDNA from the 5'-end portion of the gene was further generated by polymerase chain reaction. These two cDNAs were used to construct a cDNA encoding the entire sequence of rat sialidase. The composite sequence encodes an open reading frame of 379 amino acids that include all sequenced peptides. Although the deduced amino acid sequence is not largely similar to those of bacterial and parasite sialidases, it contains two Asp blocks, the conserved sequence of the sialidases from these microorganisms. When the cDNA was inserted into an expression vector followed by transformation in Escherichia coli, sialidase activity appeared in the cell extract. The sialidase could be completely immunoprecipitated by antiserum against the cytosolic sialidase of rat skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253770

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin.

Authors:  J P Langedijk; F J Daus; J T van Oirschot
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Sialidase significance for cancer progression.

Authors:  Taeko Miyagi; Kohta Takahashi; Keiko Hata; Kazuhiro Shiozaki; Kazunori Yamaguchi
Journal:  Glycoconj J       Date:  2012-05-29       Impact factor: 2.916

3.  Limited inhibitory effects of oseltamivir and zanamivir on human sialidases.

Authors:  Keiko Hata; Koichi Koseki; Kazunori Yamaguchi; Setsuko Moriya; Yasuo Suzuki; Sangchai Yingsakmongkon; Go Hirai; Mikiko Sodeoka; Mark von Itzstein; Taeko Miyagi
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

Review 4.  Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.

Authors:  Alexey V Pshezhetsky; Aleksander Hinek
Journal:  Glycoconj J       Date:  2011-09-20       Impact factor: 2.916

5.  Degradation of G(M1) and G(M2) by mammalian sialidases.

Authors:  S C Li; Y T Li; S Moriya; T Miyagi
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

6.  Evidence for mitochondrial localization of a novel human sialidase (NEU4).

Authors:  Kazunori Yamaguchi; Keiko Hata; Koichi Koseki; Kazuhiro Shiozaki; Hirotoshi Akita; Tadashi Wada; Setsuko Moriya; Taeko Miyagi
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

Review 7.  Recent development in mammalian sialidase molecular biology.

Authors:  Eugenio Monti; Augusto Preti; Bruno Venerando; Giuseppe Borsani
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 8.  Regulation of intracellular signaling by extracellular glycan remodeling.

Authors:  Randy B Parker; Jennifer J Kohler
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

9.  Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression.

Authors:  Yoichiro Kakugawa; Tadashi Wada; Kazunori Yamaguchi; Hideaki Yamanami; Kiyoaki Ouchi; Ikuro Sato; Taeko Miyagi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

Review 10.  Sialidase and malignancy: a minireview.

Authors:  Taeko Miyagi; Tadashi Wada; Kazunori Yamaguchi; Keiko Hata
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.